European Healthtech startup funding raised during H2 2018.
In H2 2018, 123 European Healthtech companies raised a combined €1.3B across 125 funding rounds, down 22.7% versus H2 2017. France led by capital raised, and Bpifrance was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Other | Nov 2018 | €178M |
| Acticor biotech | Series B | Nov 2018 | €153M |
| Galecto Biotech | Series C | Oct 2018 | €79M |
| MeMed | Series C |
5 exits.
| Sep 2018 |
| €60M |
| Docly | Other | Sep 2018 | €54M |
| Inflazome | Series B | Nov 2018 | €40M |
| Camel-IDS | Series A | Nov 2018 | €37M |
| Min Doktor | Other | Sep 2018 | €32M |
| Owlstone Medical | Other | Oct 2018 | €30M |
| Nuritas | Series B | Dec 2018 | €30M |
| CARMAT | Other | Dec 2018 | €30M |
| AMAL | Series B | Nov 2018 | €29M |
| Fluidic Analytics | Other | Nov 2018 | €27M |
| Whiteswell | Series B | Dec 2018 | €26M |
| Renalytix AI | Series A | Nov 2018 | €26M |
